FDA Approved: HEPZATO KIT — Supplemental Application (Delcath Systems, Inc.)

View source ↗

Summary

FDA approved a supplemental application for HEPZATO KIT, a melphalan hydrochloride injection lyophilized for solution, from Delcath Systems.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Metastases From Ocular Melanoma

Drugs mentioned

• HEPZATO KIT (melphalan hydrochloride injection, lyophilized, for solution)

Snippet

SUPPL AP for HEPZATO KIT (MELPHALAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION)